Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

1,4GlcNAc-capped mucin-type O-glycan inhibits cholesterol -glucosyltransferase from Helicobacter pylori and suppresses H. pylori growth

9 Apr 2008

Abstract excerpt

Helicobacter pylori infects over half of the world's population and is thought to be a leading cause of gastric ulcer, gastric carcinoma, and gastric malignant lymphoma of mucosa-associated lymphoid tissue type. Previously, we reported that a gland mucin (MUC6) present in the lower portion of the gastric mucosa containing alpha1,4-N-acetylglucosamine (alpha1,4GlcNAc)-capped core 2-branched O-glycans suppresses H....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Galectins and Cancer Biology
Share to Glycosylation and Glycoproteins Research
Share to Helicobacter pylori-related gastroenterology studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 18458030
DOI: 10.1093/glycob/cwn037

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

1,4GlcNAc-capped mucin-type O-glycan inhibits cholesterol -glucosyltransferase from Helicobacter pylori and suppresses H. pylori growthPMID 18458030Read ↗

Cloning of a Cholesterol-α-glucosyltransferase from Helicobacter pyloriSemantic proximity Read ↗

Cholesterol glucosylation–based survival strategy in Helicobacter pyloriSemantic proximity Read ↗

Role for α- l -fucosidase in the control of Helicobacter pylori -infected gastric cancer cellsSemantic proximity Read ↗

Cloning and Heterologous Expression of an α1,3-Fucosyltransferase Gene from the Gastric PathogenHelicobacter pyloriSemantic proximity Read ↗

Modulation of the CD4+ T-Cell Response by Helicobacter pylori Depends on Known Virulence Factors and Bacterial Cholesterol and Cholesterol α-Glucoside ContentSemantic proximity Read ↗

Helicobacter pylori Cholesteryl α-Glucosides Contribute to Its Pathogenicity and Immune Response by Natural Killer T CellsSemantic proximity Read ↗

A β‐1,4‐Galactosyltransferase from <i>Helicobacter pylori</i> is an Efficient and Versatile Biocatalyst Displaying a Novel Activity for Thioglycoside SynthesisSemantic proximity Read ↗

Cloning and Characterization of the α(1,3/4) Fucosyltransferase of Helicobacter pyloriSemantic proximity Read ↗

Functional genomics of Helicobacter pylori: identification of a beta-1,4 galactosyltransferase and generation of mutants with altered lipopolysaccharide.Semantic proximity Read ↗

Natural Antibiotic Function of a Human Gastric Mucin Against <i>Helicobacter pylori</i> InfectionSemantic proximity Read ↗

Semi-rationally designed site-saturation mutation of Helicobacter pylori α-1,2-fucosyltransferase for improved catalytic activity and thermostability.Semantic proximity Read ↗

Cj1121c, a Novel UDP-4-keto-6-deoxy-GlcNAc C-4 Aminotransferase Essential for Protein Glycosylation and Virulence in Campylobacter jejuniSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.